Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 7Thoracic 6Gastrointestinal 5Genitourinary 4Sarcoma 3Head & Neck 3Breast 3Gynecologic 2Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Endocrine 1Dermatologic 1

Conditions

Breast Neoplasms 3

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 486Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 152Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Contrast Media × Breast × Clear all
NCT05046301 2026-02-25

Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications

M.D. Anderson Cancer Center

Active not recruiting
59 enrolled
Breast

Breast Neoplasms

NCT03176979 2021-11-18

Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer

University of Southern California

Phase NA Completed
43 enrolled
Breast

Breast Neoplasms

NCT00722683 2017-10-18

Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts

University of Michigan

Phase NA Withdrawn
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡